 |
|
| ADENOSINE RECEPTORS AND PARKINSON'S DISEASE
| |
| | |
|
|
To order this title, and for more information, click here
Edited By
Hiroshi Kase, Kyowa Hakko Kogyo Co., Ltd., Tokyo, Japan
Peter Richardson, University of Cambridge, U.K.
Peter Jenner, King's College, London, U.K.
Description
This book is the first definitive overview on adenosine receptor antagonists and their application to the treatment of Parkinson's Disease.
The effect of these novel non-dopamine drugs on vitro and in vivo systems clearly shows their potential for the treatment
of this debilitating disease. This book covers how the Parkinson's disease antagonist drug, A2A, has been researched, developed, and
tested. It is an essential book for researchers interested in the basal ganglia, purine biology, and Parkinson's Disease.
Audience
Neuroscientists, neurologists, pharmacologists, biochemists, and geneticists, especially all workers in the basal ganglia, purine, and Parkinson's fields.
Contents
H. Kase, Introductory Remarks: Adenosine A2A Receptor Antagonists: A Novel Approach to the Treatment of Parkinson's Disease.
S.J. Augood, P.C. Emsom, and D.G. Standaert, Localisation of Adenosine Receptors in Brain and Periphery.J. Shimada and
F. Suzuki, Medicinal Chemistry of Adenosine Receptors in Brain and Periphery.A. Karasawa, Overview of the Physiology and
Pharmacology of Adenosine in the Peripheral System.H. Nonaka and M. Ichimura, Biochemical Characterizatoin of Adenosine Agonists
and Antagonists.A. Mori and T. Shindou, Physiology of Adenosine Receptors in the Striatum: Regulation of Striatal Projection
Neurons.P. Richardson and M. Kurokawa, The Regulation of Neurotransmitter Release in Basal Ganglia by Adenosine Receptor Agonists
and Antagonists in Vitro and in Vivo.A. Dixon and P. Richardson, Control of Gene Expression in the Basal Ganglia Induced by
Adenosine Receptors.S. Aoyama, J.-H. Baik, H. Kase, and E. Borrelli, Knockout Mice in the Study of Dopaminergic Diseases.S.
Shiozaki, S. Ichikawa, J. Nakamura, and Y. Kuwana, Effects of Adenosine Receptors Experimental Models of Cognition and Motor Behaviour.
T. Kanda and P. Jenner, Actions of Adenosine Antagonists in a Primate Model of Parkinson's Disease.A. Tahar, R. Grondin,
L. Gregoire, A. Mori, H. Kase, and P.J. Bedard, Selective Adenosine A2A Receptor Antagonism as an Alternative Therapy for Parkinson's
Disease: A Study in Nonhuman Primates.M. Nomoto, Neurobiology of Adenosine Receptors: Adenosine and its Metabolites in Movement
Disorders.
| Bibliographic details |
Hardbound, 275 pages, publication date: OCT-1999
ISBN-13: 978-0-12-400405-4
ISBN-10: 0-12-400405-9
Imprint: ACADEMIC PRESS
|
| Price and Ordering |
Price:
GBP 110
USD 175
EUR 129.95
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
095/945
Last update: 7 Sep 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company